Celcuity (CELC) is planning to raise $18 million in an initial public offering (IPO) on Wednesday, September 20th, IPO Scoop reports. The company will be issuing 2,000,000 shares at $8.00-$10.00 per share.
Celcuity has a market cap of $84.3 million.
Craig-Hallum Capital Group served as the underwriter for the IPO.
Celcuity provided the following description of their company for its IPO: ” We are a cellular analysis company that is discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. Our proprietary CELx diagnostic platform is the only commercially ready technology we are aware of that uses a patient’s living tumor cells to identify the specific abnormal cellular process driving a patient’s cancer and the targeted therapy that best treats it. “.
Celcuity was founded in 2012 and has 15 employees. The company is located at 16305 36th Avenue N., Suite 450, Minneapolis, M 55446, US and can be reached via phone at (763) 392-0123 or on the web at http://www.celcuity.com.
Receive News & Ratings for Celcuity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celcuity and related companies with MarketBeat.com's FREE daily email newsletter.